Oui, la chirurgie comporte des risques comme l'infection, la perte de fonction et des saignements.
ChirurgieComplicationsChondrosarcome
#5
Les complications affectent-elles la qualité de vie ?
Oui, les complications peuvent significativement affecter la qualité de vie des patients.
Qualité de vieChondrosarcomeComplications
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque ?
Les facteurs incluent des antécédents familiaux, des maladies génétiques et des expositions environnementales.
Facteurs de risqueChondrosarcomeAntécédents familiaux
#2
Les personnes jeunes sont-elles plus à risque ?
Le chondrosarcome peut survenir à tout âge, mais il est plus fréquent chez les jeunes adultes.
Jeunes adultesChondrosarcomeFacteurs de risque
#3
Les maladies osseuses prédisposent-elles ?
Oui, certaines maladies osseuses comme la maladie de Paget peuvent augmenter le risque.
Maladie de PagetChondrosarcomeFacteurs de risque
#4
L'obésité est-elle un facteur de risque ?
Des études suggèrent que l'obésité pourrait être un facteur de risque pour certains cancers, y compris le chondrosarcome.
ObésitéChondrosarcomeFacteurs de risque
#5
Les antécédents de radiothérapie augmentent-ils le risque ?
Oui, les antécédents de radiothérapie pour d'autres cancers peuvent augmenter le risque de chondrosarcome.
RadiothérapieChondrosarcomeFacteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chondrosarcome mésenchymateux : Questions médicales les plus fréquentes",
"headline": "Chondrosarcome mésenchymateux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chondrosarcome mésenchymateux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-09",
"dateModified": "2025-01-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chondrosarcome mésenchymateux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Chondrosarcome",
"url": "https://recherchemedicale.com/mesh/D002813",
"about": {
"@type": "MedicalCondition",
"name": "Chondrosarcome",
"code": {
"@type": "MedicalCode",
"code": "D002813",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.450.795.300"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Chondrosarcome mésenchymateux",
"alternateName": "Chondrosarcoma, Mesenchymal",
"code": {
"@type": "MedicalCode",
"code": "D018211",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Piotr Rutkowski",
"url": "https://recherchemedicale.com/author/Piotr%20Rutkowski",
"affiliation": {
"@type": "Organization",
"name": "Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland."
}
},
{
"@type": "Person",
"name": "Monika Dudzisz-Śledź",
"url": "https://recherchemedicale.com/author/Monika%20Dudzisz-%C5%9Aled%C5%BA",
"affiliation": {
"@type": "Organization",
"name": "Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland."
}
},
{
"@type": "Person",
"name": "Agnieszka E Zając",
"url": "https://recherchemedicale.com/author/Agnieszka%20E%20Zaj%C4%85c",
"affiliation": {
"@type": "Organization",
"name": "Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland."
}
},
{
"@type": "Person",
"name": "Jakub Piątkowski",
"url": "https://recherchemedicale.com/author/Jakub%20Pi%C4%85tkowski",
"affiliation": {
"@type": "Organization",
"name": "Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, 02-106 Warsaw, Poland."
}
},
{
"@type": "Person",
"name": "Anna M Czarnecka",
"url": "https://recherchemedicale.com/author/Anna%20M%20Czarnecka",
"affiliation": {
"@type": "Organization",
"name": "Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Case report: A mesenchymal chondrosarcoma with alternative",
"datePublished": "2024-08-06",
"url": "https://recherchemedicale.com/article/39165647",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/pore.2024.1611730"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mesenchymal chondrosarcoma: An Australian multi-centre cohort study.",
"datePublished": "2022-05-23",
"url": "https://recherchemedicale.com/article/35603739",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cam4.4849"
}
},
{
"@type": "ScholarlyArticle",
"name": "A mesenchymal chondrosarcoma with aberrant nuclear expression of STAT6: a potential diagnostic pitfall.",
"datePublished": "2022-02-11",
"url": "https://recherchemedicale.com/article/35217266",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.prp.2022.153803"
}
},
{
"@type": "ScholarlyArticle",
"name": "Repeated robotic pancreatectomy for recurrent pancreatic metastasis of mesenchymal chondrosarcoma: A case report.",
"datePublished": "2023-08-13",
"url": "https://recherchemedicale.com/article/37574440",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/ases.13240"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intramuscular mesenchymal chondrosarcoma surrounded by a split fat sign mimicking a benign lesion.",
"datePublished": "2024-07-29",
"url": "https://recherchemedicale.com/article/39074934",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2024-261103"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Recherchemedicale.com",
"item": "https://recherchemedicale.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tumeurs",
"item": "https://recherchemedicale.com/mesh/D009369"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs par type histologique",
"item": "https://recherchemedicale.com/mesh/D009370"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs du tissu conjonctif et des tissus mous",
"item": "https://recherchemedicale.com/mesh/D018204"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sarcomes",
"item": "https://recherchemedicale.com/mesh/D012509"
},
{
"@type": "ListItem",
"position": 6,
"name": "Chondrosarcome",
"item": "https://recherchemedicale.com/mesh/D002813"
},
{
"@type": "ListItem",
"position": 7,
"name": "Chondrosarcome mésenchymateux",
"item": "https://recherchemedicale.com/mesh/D018211"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chondrosarcome mésenchymateux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chondrosarcome mésenchymateux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-02-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chondrosarcome mésenchymateux",
"description": "Comment diagnostique-t-on un chondrosarcome mésenchymateux ?\nQuels examens d'imagerie sont utilisés ?\nQuels marqueurs tumoraux sont associés ?\nLe diagnostic précoce est-il important ?\nPeut-on confondre ce cancer avec d'autres ?",
"url": "https://recherchemedicale.com/mesh/D018211#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chondrosarcome mésenchymateux",
"description": "Quels sont les symptômes courants ?\nLa douleur est-elle constante ?\nY a-t-il des symptômes systémiques ?\nLes symptômes varient-ils selon l'âge ?\nPeut-on avoir des symptômes sans tumeur visible ?",
"url": "https://recherchemedicale.com/mesh/D018211#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chondrosarcome mésenchymateux",
"description": "Peut-on prévenir le chondrosarcome ?\nLes facteurs génétiques jouent-ils un rôle ?\nL'exposition à des substances chimiques est-elle un risque ?\nLe mode de vie influence-t-il le risque ?\nDes vaccinations peuvent-elles aider ?",
"url": "https://recherchemedicale.com/mesh/D018211#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chondrosarcome mésenchymateux",
"description": "Quel est le traitement principal ?\nLa radiothérapie est-elle efficace ?\nDes traitements médicamenteux existent-ils ?\nQuelle est l'importance du suivi post-traitement ?\nY a-t-il des essais cliniques disponibles ?",
"url": "https://recherchemedicale.com/mesh/D018211#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chondrosarcome mésenchymateux",
"description": "Quelles sont les complications possibles ?\nLe chondrosarcome peut-il métastaser ?\nComment gérer la douleur chronique ?\nY a-t-il des risques liés à la chirurgie ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://recherchemedicale.com/mesh/D018211#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chondrosarcome mésenchymateux",
"description": "Quels sont les principaux facteurs de risque ?\nLes personnes jeunes sont-elles plus à risque ?\nLes maladies osseuses prédisposent-elles ?\nL'obésité est-elle un facteur de risque ?\nLes antécédents de radiothérapie augmentent-ils le risque ?",
"url": "https://recherchemedicale.com/mesh/D018211#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on un chondrosarcome mésenchymateux ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'imagerie (IRM, scanner) et la biopsie pour confirmer la nature tumorale."
}
},
{
"@type": "Question",
"name": "Quels examens d'imagerie sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM et le scanner sont couramment utilisés pour évaluer la taille et l'étendue de la tumeur."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont associés ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de marqueurs spécifiques, mais des analyses histologiques sont essentielles."
}
},
{
"@type": "Question",
"name": "Le diagnostic précoce est-il important ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un diagnostic précoce améliore les chances de traitement efficace et de survie."
}
},
{
"@type": "Question",
"name": "Peut-on confondre ce cancer avec d'autres ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec d'autres tumeurs osseuses, nécessitant une analyse minutieuse."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur osseuse, gonflement et parfois des fractures pathologiques."
}
},
{
"@type": "Question",
"name": "La douleur est-elle constante ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur peut être intermittente au début, mais devient souvent persistante avec le temps."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes systémiques comme la fatigue ou la perte de poids peuvent survenir dans les stades avancés."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon l'âge et la localisation de la tumeur."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans tumeur visible ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs peuvent exister sans tumeur visible, nécessitant des examens approfondis."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le chondrosarcome ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Les facteurs génétiques jouent-ils un rôle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de tumeurs osseuses peuvent augmenter le risque de chondrosarcome."
}
},
{
"@type": "Question",
"name": "L'exposition à des substances chimiques est-elle un risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines expositions professionnelles à des produits chimiques peuvent être un facteur de risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut réduire le risque de nombreuses maladies, mais pas spécifiquement le chondrosarcome."
}
},
{
"@type": "Question",
"name": "Des vaccinations peuvent-elles aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiques pour prévenir le chondrosarcome."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est la chirurgie pour enlever la tumeur, si possible."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie peut être utilisée en complément, mais elle n'est pas le traitement principal."
}
},
{
"@type": "Question",
"name": "Des traitements médicamenteux existent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements médicamenteux comme les analgésiques peuvent aider à gérer la douleur."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance du suivi post-traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier est crucial pour détecter toute récidive ou complications."
}
},
{
"@type": "Question",
"name": "Y a-t-il des essais cliniques disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des essais cliniques peuvent offrir des options de traitement innovantes pour les patients."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la récidive tumorale, la douleur chronique et des fractures osseuses."
}
},
{
"@type": "Question",
"name": "Le chondrosarcome peut-il métastaser ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, bien que rare, le chondrosarcome peut métastaser, surtout dans les stades avancés."
}
},
{
"@type": "Question",
"name": "Comment gérer la douleur chronique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur chronique peut être gérée par des analgésiques, la physiothérapie et des interventions ciblées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques liés à la chirurgie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chirurgie comporte des risques comme l'infection, la perte de fonction et des saignements."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies génétiques et des expositions environnementales."
}
},
{
"@type": "Question",
"name": "Les personnes jeunes sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le chondrosarcome peut survenir à tout âge, mais il est plus fréquent chez les jeunes adultes."
}
},
{
"@type": "Question",
"name": "Les maladies osseuses prédisposent-elles ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies osseuses comme la maladie de Paget peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "L'obésité est-elle un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que l'obésité pourrait être un facteur de risque pour certains cancers, y compris le chondrosarcome."
}
},
{
"@type": "Question",
"name": "Les antécédents de radiothérapie augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents de radiothérapie pour d'autres cancers peuvent augmenter le risque de chondrosarcome."
}
}
]
}
]
}
Mesenchymal chondrosarcoma (MCS) is a rare subtype of chondrosarcoma that occurs at widespread anatomical locations, such as bone, soft tissue, and intracranial sites. The central nervous system (CNS)...
We report a case of intracranial MCS with...
Cartilaginous components were often not apparent during the recurrences. In addition to the non-typical pathological finding, the correct diagnosis was hampered by the poor RNA quality of the surgical...
This is the first reported case of intracranial MCS with an alternative...
Mesenchymal chondrosarcoma (MCS) is an ultra-rare sarcoma that follows a more aggressive course than conventional chondrosarcoma. This study evaluates prognostic factors, treatments (surgery, chemothe...
We collected demographics, clinicopathological variables, treatment characteristics, and survival status from patients with MCS registered on the national ACCORD sarcoma database. Outcomes include ove...
We identified 22 patients with MCS between 2001-2022. Median age was 28 (range 10-59) years, 19 (86%) had localised disease at diagnosis of whom 16 had surgery (84%), 11 received radiation (58%), and ...
This study demonstrates contemporary Australian treatment patterns of MCS. The role of chemotherapy for localised disease remains uncertain. Understanding treatment patterns and outcomes help support ...
STAT6 is usually considered to be a very sensitive and specific immunomarker for diagnosis of solitary fibrous tumor (SFT), being a surrogate of the NAB2-STAT6 fusion gene identified in most cases of ...
Mesenchymal chondrosarcoma is a rare subset of sarcomas accounting for 3%-10% of all cases of chondrosarcomas. Radical resection is the only curative strategy, even in patients with metastatic tumors....
Mesenchymal chondrosarcoma (MCS) is an aggressive malignant mesenchymal tumour of uncertain differentiation. This is rare, accounting for 2%-4% of chondrosarcomas. Its peak incidence is in the second ...
Chondrosarcomas are an exceedingly rare form of cancer, impacting only a few individuals per million. Among chondrosarcomas, a small fraction belongs to the mesenchymal sub-type. Furthermore, only one...
A 38-year-old woman was referred by a midwife after experiencing pain in the right upper quadrant of her right breast for 2 months. The mass had been palpable for 1 week before the initial assessment....
Given the tumor's rarity and the lack of established guidelines, diagnosing EMCS can be challenging and prone to errors. As such, meticulous sampling, along with precise pathological and imaging inves...
Mesenchymal chondrosarcoma (MCS) is a rare and highly aggressive tumour of soft tissue and bone that is defined by an underlying and highly specific fusion transcript involving HEY1 and NCOA2. Histolo...
Mesenchymal chondrosarcoma (MCS) is an ultra-rare, high-grade subtype of chondrosarcoma affecting both bone and soft tissues. Extra-skeletal MCS rarely occurs in intra- and extradural regions....
We presented a case of intraspinal dumbbell-shaped MCS at the T12-L2 level with isolated punctate calcification in a 19-year-old male complaining of progressive lower back pain. Surgical treatment for...
CT and MRI play an important role in differential diagnosis for intraspinal MCS. MCS should be added to the differential diagnosis of intraspinal dumbbell-shaped tumors, especially when radiological e...
Mesenchymal chondrosarcoma (MCS) is a rare translocation-associated sarcoma, driven by a canonical HEY1::NCOA2 fusion. The tumors typically have a biphasic phenotype of primitive small blue round cell...
We assembled a relatively large cohort of 13 molecularly confirmed HN MCS for a detailed clinicopathologic analysis. The underlying fusion events were determined using fluorescence in situ hybridizati...
The median age of presentation was 19 years. Five MCSs (39%) had an intraosseous presentation (skull, maxilla, palate, and mandible), while the remaining eight cases occurred in the brain/meninges, or...
HN MCS may arise at intra- or extra-osseous sites. The HN MCS appears to have a more prolonged survival compared other MCS sites. Testing for HEY1::NCOA2 fusion is recommended in HN tumors with nested...
Mesenchymal chondrosarcoma is a rare, high-grade, primitive mesenchymal tumor. It accounts for around 2-10% of all chondrosarcomas and mainly affects adolescents and young adults. We previously descri...